您的位置 : 首页 / MAPK/ERK Pathway / MEK / PD-184161
PD184161 is an orally-active MEK inhibitor with antitumor effects in HCC in vitro and in vivo that appear to correlate with suppression of MEK activity.
18817579266
实验数据
技术信息
生物活性